GlassScriptPhysician profile
Carmelo A Plateroti
NPI 1275556029
$12,712.80
in general payments reported to CMS, 2019-2025
35 companies · $2,284 in 2025
The $2,284 reported for 2025 was more than what 79% of Dermatology providers received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,645 · 2020: $823 · 2021: $1,317 · 2022: $1,984 · 2023: $2,211 · 2024: $2,450 · 2025: $2,284.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,920 · Education: $24.92.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,919.97 |
| Education | $24.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $3,078.80 | 2019-2025 | |
| Genzyme Corporation | $974.24 | 2019-2025 | |
| Lilly USA, LLC | $874.13 | 2019-2025 | Taltz, Olumiant, Ebglyss |
| Pfizer INC. | $832.47 | 2023-2025 | |
| Novartis Pharmaceuticals Corporation | $803.34 | 2019-2025 | |
| Regeneron Healthcare Solutions, INC. | $684.86 | 2019-2025 | Dupixent |
| Allergan, INC. | $619.30 | 2019-2022 | |
| Janssen Biotech, INC. | $559.53 | 2019-2025 | Tremfya |
| Prugen, INC. Pharmaceuticals | $543.09 | 2019-2020 | |
| Ucb, INC. | $521.87 | 2019-2025 | Cimzia, Bimzelx |
| E.R. Squibb & Sons, L.L.C. | $513.01 | 2022-2025 | Sotyktu |
| Incyte Corporation | $448.22 | 2022-2025 | Opzelura |
| Sun Pharmaceutical Industries INC. | $400.98 | 2019-2024 | |
| Galderma Laboratories, L.P. | $344.08 | 2020-2025 | Nemluvio, Aklief |
| Organogenesis INC. | $284.60 | 2024-2025 | Affinity, Novachor |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $230.63 | 2020-2024 | Otezla |
| Arcutis Biotherapeutics, INC. | $195.54 | 2023-2025 | Zoryve |
| Revance Therapeutics, INC. | $89.44 | 2024-2025 | Daxxify |
| Genentech USA, INC. | $86.13 | 2019-2021 | |
| Celgene Corporation | $84.18 | 2019 | |
| Dermavant Sciences, INC. | $66.61 | 2022-2023 | Vtama |
| Sanofi-Aventis U.S. LLC | $56.74 | 2019 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $55.65 | 2022 | |
| Almirall LLC | $48.36 | 2022-2023 | Klisyri |
| Boehringer Ingelheim Pharmaceuticals, INC. | $47.64 | 2022-2023 | Spevigo |
| Organon LLC | $47.13 | 2025 | |
| Leo Pharma INC. | $44.17 | 2025 | Anzupgo, Adbry |
| Biofrontera INC. | $33.25 | 2019-2020 | |
| Journey Medical Corporation | $28.26 | 2020-2022 | |
| Dermira, INC. | $23.33 | 2020 | |
| Dusa Pharmaceuticals, INC. | $23.16 | 2019 | |
| Musculoskeletal Transplant Foundation INC. | $21.09 | 2022 | |
| Pierre Fabre Pharmaceuticals, INC. | $17.63 | 2019 | |
| Epi Health, LLC | $17.08 | 2021 | |
| Helsinn Therapeutics (U.S.), INC. | $14.26 | 2023 | Valchlor |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Carmelo Plateroti listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.